Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors

J Neurosci. 2009 Jul 1;29(26):8493-505. doi: 10.1523/JNEUROSCI.1321-09.2009.

Abstract

The cAMP cascade and vascular endothelial growth factor (VEGF) are critical modulators of depression. Here we have tested whether the antidepressive effect of the cAMP cascade is mediated by VEGF in the adult hippocampus. We used a conditional genetic system in which the Aplysia octopamine receptor (Ap oa(1)), a G(s)-coupled receptor, is transgenically expressed in the forebrain neurons of mice. Chronic activation of the heterologous Ap oa(1) by its natural ligand evoked antidepressant-like behaviors, accompanied by enhanced phosphorylation of cAMP response element-binding protein and transcription of VEGF in hippocampal dentate gyrus (DG) neurons. Selective knockdown of VEGF in these cells during the period of cAMP elevation inhibited the antidepressant-like behaviors. These findings reveal a molecular interaction between the cAMP cascade and VEGF expression, and the pronounced behavioral consequences of this interaction shed light on the mechanism underlying neuronal VEGF functions in antidepression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Antidepressive Agents, Second-Generation / pharmacology
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Brain-Derived Neurotrophic Factor / metabolism
  • Bromodeoxyuridine / metabolism
  • CREB-Binding Protein / metabolism
  • Cell Line, Transformed
  • Chromatin Immunoprecipitation / methods
  • Cyclic AMP / metabolism
  • Cyclic AMP / pharmacology*
  • Dentate Gyrus / cytology*
  • Depression* / genetics
  • Depression* / pathology
  • Disease Models, Animal
  • Electrophoretic Mobility Shift Assay / methods
  • Exploratory Behavior
  • Feeding Behavior
  • Fluoxetine / pharmacology
  • Food Preferences / drug effects
  • Food Preferences / physiology
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / physiology
  • Humans
  • Male
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurogenesis / drug effects
  • Neurogenesis / genetics
  • Neurons / drug effects
  • Neurons / metabolism*
  • Octopamine / pharmacology
  • RNA, Small Interfering / genetics
  • Receptors, Biogenic Amine / genetics
  • Transfection / methods
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Antidepressive Agents, Second-Generation
  • Brain-Derived Neurotrophic Factor
  • RNA, Small Interfering
  • Receptors, Biogenic Amine
  • Vascular Endothelial Growth Factor A
  • Vasoconstrictor Agents
  • norsynephrine receptor
  • Fluoxetine
  • Octopamine
  • Cyclic AMP
  • CREB-Binding Protein
  • Bromodeoxyuridine